Nidan Laboratories and Healthcare Limited

NSEI:NIDAN Stock Report

Market Cap: ₹419.1m

Nidan Laboratories and Healthcare Balance Sheet Health

Financial Health criteria checks 4/6

Nidan Laboratories and Healthcare has a total shareholder equity of ₹713.6M and total debt of ₹142.5M, which brings its debt-to-equity ratio to 20%. Its total assets and total liabilities are ₹888.9M and ₹175.3M respectively. Nidan Laboratories and Healthcare's EBIT is ₹20.3M making its interest coverage ratio -2.4. It has cash and short-term investments of ₹64.4M.

Key information

20.0%

Debt to equity ratio

₹142.49m

Debt

Interest coverage ratio-2.4x
Cash₹64.43m
Equity₹713.61m
Total liabilities₹175.27m
Total assets₹888.88m

Recent financial health updates

No updates

Recent updates

With EPS Growth And More, Nidan Laboratories and Healthcare (NSE:NIDAN) Makes An Interesting Case

Jul 19
With EPS Growth And More, Nidan Laboratories and Healthcare (NSE:NIDAN) Makes An Interesting Case

Nidan Laboratories and Healthcare (NSE:NIDAN) Will Want To Turn Around Its Return Trends

Jan 20
Nidan Laboratories and Healthcare (NSE:NIDAN) Will Want To Turn Around Its Return Trends

Financial Position Analysis

Short Term Liabilities: NIDAN's short term assets (₹204.0M) exceed its short term liabilities (₹126.0M).

Long Term Liabilities: NIDAN's short term assets (₹204.0M) exceed its long term liabilities (₹49.3M).


Debt to Equity History and Analysis

Debt Level: NIDAN's net debt to equity ratio (10.9%) is considered satisfactory.

Reducing Debt: Insufficient data to determine if NIDAN's debt to equity ratio has reduced over the past 5 years.

Debt Coverage: NIDAN's debt is not well covered by operating cash flow (4.6%).

Interest Coverage: NIDAN earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.